Swiss National Bank
IMDZ

Swiss National Bank’s Immune Design Corp. IMDZ Stock Holding History

Swiss National Bank’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-17,300
Closed -$131K – 2603
2016
Q3 		$131K Buy
17,300
+4,800
+38% +$35.1K ﹤0.01% 2530
2016
Q2 		$102K Buy
12,500
+1,600
+15% +$20K ﹤0.01% 2575
2016
Q1 		$136K Buy
10,900
+2,500
+30% +$28.9K ﹤0.01% 2588
2015
Q4 		$169K Hold
8,400
– – ﹤0.01% 2603
2015
Q3 		$102K Buy
8,400
+1,400
+20% +$26.2K ﹤0.01% 2553
2015
Q2 		$145K Buy
+7,000
New +$165K ﹤0.01% 2568

Other funds holding IMDZ

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Swiss National Bank's IMDZ Position: Q4 2016 in Review

Swiss National Bank sold out of Immune Design Corp. (IMDZ) in Q4 2016, closing a stake of 17,300 shares — an estimated $131K sold.

Swiss National Bank first reported a position in IMDZ in Q2 2015 and held it in 6 quarters. The position peaked at $169K in Q4 2015. 65 funds tracked by Wall St. Rank hold IMDZ as of Q4 2016.

  • Swiss National Bank reported no remaining Immune Design Corp. position as of Q4 2016 after selling out during the quarter.
  • Swiss National Bank sold 17,300 Immune Design Corp. shares in Q4 2016, an estimated $131K.
  • Swiss National Bank first reported a position in Immune Design Corp. in Q2 2015 and held it in 6 quarters.
  • Swiss National Bank's Immune Design Corp. position peaked at $169K in Q4 2015.
  • 65 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2016.

Based on Swiss National Bank's 13F filing for Q4 2016, filed 8 Feb 2017.